You are here

PH94B

VistaGen finds open-label success with social anxiety nasal spray, but PALISADE pivotal trial remains iced

Fierce Biotech

Wed, 03/22/23 - 09:21 pm

Vistagen, jittery after seeing rivals fail, pauses plan to restart phase 3 anxiety trial pending FDA talks

Fierce Biotech

Wed, 02/8/23 - 10:27 am

clinical trials

VistaGen can’t puff out phase 3 success for social anxiety nasal spray

Fierce Biotech

Fri, 07/22/22 - 11:24 am

clinical trials

VistaGen says regulators couldn’t sniff out abuse potential of its nasal spray for social anxiety

Fierce Biotech

Sun, 05/8/22 - 12:14 pm

clinical trials